Determination of HPRT mutant frequency and molecular analysis of T- lymphocyte mutants derived from coke-oven workers

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 412, Issue 2, 1998, Pages 177-186

  Zanesi, Nicola ^a   Mognato, Maddalena ^a   Pizzato, Massimo ^a   Viezzer, Cristina ^a   Ferri, Giovanni ^b   Celotti, Lucia ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Hprt locus; MP PCR; Mutant frequency; PAH exposure; RT PCR

Indexed keywords

HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ARTICLE; GENE LOCUS; HUMAN; HUMAN CELL; MUTAGENICITY; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; SMOKING; T LYMPHOCYTE;

ADULT; AGE FACTORS; COKE; DNA MUTATIONAL ANALYSIS; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INDUSTRY; MIDDLE AGED; MUTAGENS; MUTATION; OCCUPATIONAL EXPOSURE; POLYCYCLIC HYDROCARBONS, AROMATIC; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 0032579153     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(97)00190-3     Document Type: Article

References (35)

1. Edwards A., Voss H., Rice P., Civitello A., Stagemann J., Schwager C., Zimmerman J., Erfle H., Caskey C.T. Automated DNA sequencing of the human hprt-locus. Genomics. 6:1990;593-608.
2. Nicklas J.A., Falta M.T., Hunter T.C., O'Neill J.P., Jacobson-Kram D., Williams J.R., Albertini R.J. Molecular analysis of in vivo hprt mutations in human T lymphocytes. V. Effects of total body irradiation secondary to radioimmunoglobulin therapy (RIT). Mutagenesis. 5:1990;461-468.
3. Fuscoe J.C., Zimmerman L.J., Harrington-Brock K., Moore M.M. Large deletions are tolerated at the hprt locus of in vivo derived human T-lymphocytes. Mutation Res. 283:1992;255-262.
4. Morris T., Masson W., Singleton B., Thacker J. Analysis of large deletions in the hprt gene of primary human fibroblasts using the polymerase chain reaction. Somat. Cell Mol. Genet. 19:1993;9-19.
5. Perera F.P., Tang D.L., O'Neill J.P., Bigbee W.L., Albertini R., Santella R., Ottman R., Tsai W.Y., Dickey C., Mooney L.A., Savela K., Hemminki K. HPRT and glycophorin a mutations in foundry workers: relationship to PAH exposure and to PAH-DNA adducts. Carcinogenesis. 14:1993;969-973.
6. Perera F.P., Dickey C., Santella R., O'Neill J.P., Albertini R., Ottman R., Tsai W.Y., Mooney L.A., Savela K., Hemminki K. Carcinogen-DNA adducts and gene mutation in foundry workers with low-level exposure to polycyclic aromatic hydrocarbons. Carcinogenesis. 15:1994;2905-2910.
7. Krieck E., van Shooten F.J., Hillebrand M.J.X., van Leeuwen F.J., de Engelse L., de Looff A.J.A., Dukmans A.P.G. DNA adducts as a measure of lung cancer risk in humans exposed to polycyclic aromatic hydrocarbons. Environ. Health Perspect. 99:1993;71-75.
8. Hou S.M., Fält S., Steen A.-M. Hprt mutant frequency and GSTM1 genotype in non-smoking healthy individuals. Environ. Mol. Mutagen. 25:1995;97-105.
9. Wei S.J., Chang R.L., Hennig E., Cui X.X., Merkler K.A., Wong C.Q., Yagi H., Jerina D.M., Conney A.H. Mutagenic selectivity at the HPRT locus in V-79 cells: comparison of mutations caused by bay-region benzo(a)pyrene 7,8-diol-9,-10-epoxide enantiomers with high and low carcinogenic activity. Carcinogenesis. 15:1994;1729-1735.
10. Celotti L., Viezzer C., Pavanello S., Ferraro P., Levis A.G., Ferri G., Foà V. DNA adduct levels in peripheral blood lymphocytes of coke-oven workers. J. Clean Technol. Environ. Toxicol. Occup. Med. 5:1996;167-177.
11. Clonfero E., Granella M., Marchioro M., Leopardi Barra E., Nardini B., Ferri G., Foà V. Urinary excretion to mutagens in coke oven workers. Carcinogenesis. 16:1995;547-554.
12. Albertini R.J., Castle K.L., Borcherding W.R. T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood. Proc. Natl. Acad. Sci. USA. 79:1982;6617-6621.
13. Zanesi N., Ferraro P., Pavanello S., Furlan D., Celotti L. Cytotoxic and mutagenic effects of anti- and syn-benzo[a]pyrene diol epoxide in human lymphocytes. Toxicol. Vitro. 8:1994;1269-1275.
14. He S.-M., Holmberg K., Lambert B., Einhorn N. Hprt mutations and karyotype abnormalities in T-cell clones from healthy subjects and melphalan-treated ovarian carcinoma patients. Mutation Res. 210:1989;353-358.
15. Gibbs R.A., Nguyen P.-N., Edwards A., Civitello A.B., Caskey C.T. Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan families. Genomics. 7:1990;235-244.
16. Österholm A.-M., Fält S., Lambert B., Hou S.-M. Classification of mutations at the human hprt-locus in T-lymphocytes of bus maintenance workers by multiplex-PCR and reverse transcriptase-PCR analysis. Carcinogenesis. 16:1995;1909-1912.
17. Fuscoe J.C., Zimmerman L.J., Harrington-Brock K., Moore M.M. Multiplex PCR analysis of in vivo-arising deletion mutations in the hprt gene of human T-lymphocytes. Environ. Mol. Mutagen. 23:1994;89-95.
18. Yang J.L., Maher V.M., McCormick J.J. Amplification and direct nucleotide sequencing of cDNA from the lysate of low numbers of diploid human cells. Gene. 83:1989;347-354.
19. Jones I.M., Moore D.H., Thomas C.B., Thompson C.L., Strout C.L., Burkhart-Schultz K. Factors affecting HPRT mutant frequency in T-lymphocytes of smokers and nonsmokers. Cancer Epidemiol. Biomarkers Prev. 2:1993;249-260.
20. Cole J., Skopek T.R. Somatic mutation frequency, mutation rates and mutational spectra in human population in vivo. Mutation Res. 304:1994;33-105.
21. Tates A.D., van Dam F.J., van Mossel H., Schoemaker H., Thijssen J.C., Woldring V.M., Zwinderman A.H., Natarajan A.T. Use of the clonal assay for the measurement of frequencies of HPRT mutants in T-lymphocytes from five control populations. Mutation Res. 253:1991;199-213.
22. J. Cole, M.H.L Green, G. Stephens, A.P.W. Waugh, D. Beare, H. Steingrimsdottir, B.A. Bridges, HPRT somatic mutation data, in: M.L. Mendelsohn, R.J. Albertini (Eds.), Mutation and the Environment, Part C, Somatic and Heritable Mutation, Adduction and Epidemiology, Wiley-Liss, New York, 1990, pp. 25-35.
23. Branda R.F., Sullivan L.M., O'Neill J.P., Falta M.T., Nicklas J.A., Hirsch B., Vacek P.M., Albertini R.J. Measurement of HPRT mutant frequencies in T-lymphocytes from healthy human populations. Mutation Res. 285:1993;267-279.
24. Cole J., Green M.H.L., James S.E., Henderson L., Cole H. Human population monitoring: a further assessment of factors influencing measurements of thioguanine-resistant mutant frequency in circulating T-lymphocytes. Mutation Res. 204:1988;493-507.
25. Vodicka P., Bastlova T., Vodickova L., Peterkova K., Lambert B., Hemminki K. Biomarkers of styrene exposure in lamination workers: levels of O6-guanine DNA adducts, DNA strand breaks and mutant frequencies in the hypoxanthine guanine phosphoribosyltransferase gene in T-lymphocytes. Carcinogenesis. 16:1995;1473-1481.
26. Österholm A.-M., Bastlova T., Meijer A., Podlutsky A., Zanesi N., Hou S.-M. Sequence analysis of deletion mutations at the HPRT locus of human T-lymphocytes: association of a palindromic structure with a breakpoint cluster in exon 2. Mutagenesis. 11:1996;511-517.
27. Steingrimsdottir H., Rowley G., Waugh A., Beare D., Ceccherini I., Cole J., Lehmann A.R. Molecular analysis in hprt gene in circulating lymphocytes from normal and DNA-repair-deficient donors. Mutation Res. 294:1993;29-41.
28. Burkhart-Schultz K.J., Thompson C.L., Jones I.M. Spectrum of somatic mutation at hypoxanthine phosphoribosyltransferase (hprt) gene of healthy people. Carcinogenesis. 17:1996;1871-1883.
29. Yang J.L., Patel P.I., Chinault A.C., Stout J.T., Jackson L.G., Hildebrand B.M., Caskey C.T. Molecular evidence for new mutation at the hprt locus in Lesch-Nyhan patients. Nature. 310:1984;412-414.
30. Albertini R.J., Nicklas J.A., O'Neill J.P., Robinson S.H. In vivo somatic mutations in humans: measurement and analysis. Annu. Rev. Genet. 24:1990;305-326.
31. Pavanello S., Rojas M., Paleologo M., Levis A.G., Alexandrov K. Evidence for substantial formation of r-7,t-8-dihydroxy-c-9,10-oxy-7,8,9,10-tetrahydrobenzo(a)pyrene-deoxyguanosine in human lymphocytes treated in vitro with benzo(a)pyrene. Carcinogenesis. 10:1989;945-947.
32. 2 in a duplex dodecamer. Cancer Res. 51:1991;3482-3492.
33. Carothers A.M., Grunberger D. DNA base changes in benzo[a]pyrene diol epoxide-induced dihydrofolate reductase mutants in Chinese hamster ovary cells. Carcinogenesis. 11:1990;189-192.
34. Andersson B., Hou S.M., Lambert B. Mutations causing defective splicing in the human hprt gene. Environ. Mol. Mutagen. 20:1992;89-95.
35. Mazur M., Glickman B.W. Sequence specificity of mutations induced by benzo[a]pyrene-7,8-diol-9,10-epoxide at endogenous aprt gene in CHO cells. Somatic Cell Mol. Genet. 14:1988;393-400.